← Eichor
Study identifier: NCT07539194 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of the Performance and Safety of a Single-dose Hyaluronic Acid (Promovia Hydro Balance) in the Treatment of Non-traumatic Degenerative Meniscus Tears

Condition: Meniscus Tears  ·  Sponsor: Innate srl

PhaseNA
Planned participants25
Who can joinAll sexes, 35 Years to 75 Years
Healthy volunteersNo

About this study

Evaluation of the performance and safety of a single-dose hyaluronic acid (Promovia hydro balance) in the treatment of non-traumatic degenerative meniscus tears

This description comes directly from the study's public registry record.

Talk to the study team

Giulia Avio  ·  +393925481157  ·  giulia.avio@innate.it

Chiara Fossati, medical doctor  ·  i  ·  chiara.fossati@asst-pini-cto.it

Always discuss trial participation with your own doctor first.

Locations (1)

ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTOMilan, MI, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07539194